Skip to Content

WATSON 152 8 mg (Rapaflo 8 mg)

Generic Name: silodosin

Pill with imprint WATSON 152 8 mg is White, Capsule-shape and has been identified as Rapaflo 8 mg. It is supplied by Allergan, Inc..

Rapaflo is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Rapaflo 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 152 8 mg

Rapaflo 8 mg WATSON 152 8 mg
Rapaflo 8 mg WATSON 152 8 mg Front
Rapaflo 8 mg WATSON 152 8 mg Back
Rapaflo 8 mg WATSON 152 8 mg

Rapaflo

Generic Name:
silodosin
Imprint:
WATSON 152 8 mg
Strength:
8 mg
Color:
White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Allergan, Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide